Dalfampridine (Ampyra) for multiple sclerosis.
Jennifer M
JM
Belavic
D015761:4-Aminopyridine / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000075202:Contraindications; D003692:Delayed-Action Preparations; D006801:Humans; D009103:Multiple Sclerosis / Q000145:classification / Q000188:drug therapy* / Q000453:epidemiology; D009656:North America / Q000453:epidemiology; D009722:Nurse Practitioners; D009965:Orphan Drug Production; D026902:Potassium Channel Blockers / Q000493:pharmacokinetics / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D026902:Potassium Channel Blockers; D015761:4-Aminopyridine